H.C. Wainwright Reiterates Buy Rating on Emergent BioSolutions (EBS)
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/12/2026
- Nasdaq falls ahead of earnings, economic data while oil rallies
- Oil prices rise on Saudi Arabia attacks, overshadowing Trump's diesel deal
- Will surging equity supply derail the U.S. bull market? Goldman Sachs weighs in
- Broadcom CEO says many AI investors are gamblers
- "Not buying Chipotle": Starbucks squashes blockbuster acquisition speculation
| EMERGENT BIOSOLUTIONS, Inc. (NYSE: EBS) | Delayed: 6.98 -0.08 (1.13%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $7.06 | 52 Week High | $44.38 | |||
| Open | $7.08 | 52 Week Low | $24.47 | |||
| Day High | $7.33 | P/E | 349.00 | |||
| Day Low | $6.95 | EPS | $0.02 | |||
| Volume | 951,028 | |||||
